Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$15.51 - $17.61 $198,372 - $225,231
-12,790 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$14.52 - $19.72 $185,710 - $252,218
12,790 New
12,790 $222,000
Q2 2018

Aug 14, 2018

SELL
$13.8 - $16.8 $285,867 - $348,012
-20,715 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$13.8 - $16.2 $285,867 - $335,583
20,715 New
20,715 $294,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.